📰 Belgium Fixed News
Belgium Fixed News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Belgium Fixed. Real-time updates on events, politics, business and more.
September 5, 2023
Georges Rawadi was appointed Chief Executive Officer as from April 27, 2023Celyad Oncology has received approximately EUR 9.8m in private placement commitments from historical shareholdersEncouraging progress in multiplex shRNA platform development, which allows now targeting of up to four genes simultaneously, were...
September 4, 2023
Georges Rawadi was appointed Chief Executive Officer as from April 27, 2023Celyad Oncology has received approximately EUR 9.8m in private placement commitments from historical shareholdersEncouraging...
September 4, 2023
Georges Rawadi was appointed Chief Executive Officer as from April 27, 2023Celyad Oncology has received approximately EUR 9.8m in private placement...
March 18, 2023
MONT-SAINT-GUIBERT, Belgium--(BUSINESS WIRE)--Regulatory News:Celyad Oncology (Euronext & Nasdaq: CYAD) (the “Company”) (Brussels:CYAD) (Paris:CYAD) (NASDAQ:CYAD), a biotechnology company focused on the discovery and development of innovative technologies for chimeric antigen receptor (CAR) T-cell therapies, today a...
March 18, 2023
17.03.2023 - MONT-SAINT-GUIBERT, Belgium, March 17, 2023 (GLOBE NEWSWIRE) - Celyad Oncology (Euronext & Nasdaq: CYAD) (the “Company”), a biotechnology company focused on the discovery and development of innovative technologies for chimeric antigen receptor ... Seite 1
March 17, 2023
MONT-SAINT-GUIBERT, Belgium, March 17, 2023 (GLOBE NEWSWIRE) -- Celyad Oncology (Euronext & Nasdaq: CYAD) (the “Company”), a biotechnology company...
March 17, 2023
Regulatory News: Celyad Oncology (Euronext Nasdaq: CYAD) (the "Company") (Brussels:CYAD) (Paris:CYAD) (NASDAQ:CYAD), a biotechnology company focused on the discovery and development of innovative